1 |
Azeredo J, Pirnay JP. Editorial overview: Special issue on phage therapy. Curr Opin Virol 2022;58:101300. [PMID: 36586203 DOI: 10.1016/j.coviro.2022.101300] [Reference Citation Analysis]
|
2 |
Alaoui Mdarhri H, Benmessaoud R, Yacoubi H, Seffar L, Guennouni Assimi H, Hamam M, Boussettine R, Filali-Ansari N, Lahlou FA, Diawara I, Ennaji MM, Kettani-Halabi M. Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine. Antibiotics (Basel) 2022;11. [PMID: 36551487 DOI: 10.3390/antibiotics11121826] [Reference Citation Analysis]
|
3 |
Yilmaz M, Aksin Ş, Balsak D, Avci F, Özdoğru O, Helvacıoğlu B, Erdemoğlu M, Aboalhasan Y, Doğan G, Ferrari FG. Comparison of Perinatal, Newborn, and Audiometry Results of COVID-19 Pregnant Women. International Journal of Clinical Practice 2022;2022:1-7. [DOI: 10.1155/2022/2699532] [Reference Citation Analysis]
|
4 |
Boyanova L, Markovska R, Mitov I, Gergova R. Non-viral infections and antimicrobial resistance in the time of COVID-19: what to expect? Expert Rev Clin Pharmacol 2022. [PMID: 35912839 DOI: 10.1080/17512433.2022.2108403] [Reference Citation Analysis]
|
5 |
Bai G, Lin S, Hsu Y, Chen S. The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications. Viruses 2022;14:278. [DOI: 10.3390/v14020278] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
|
6 |
Su Y, Ding M, Dong H, Hu Y, Yang D, Shao J, Huang B. Recent advances in nanozymes for combating bacterial infection. Mater Chem Front . [DOI: 10.1039/d2qm00511e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|